Jacobio Pharmaceuticals Group Co., Ltd. (HKG:1167)

HKG:1167 Revenue

Jacobio Pharmaceuticals Group had revenue of 730.87M CNY in the half year ending June 30, 2026. This brings the company's revenue in the last twelve months to 738.73M, up 266.85% year-over-year. In the year 2025, Jacobio Pharmaceuticals Group had annual revenue of 53.53M, down -65.62%.

• Revenue (ttm): 738.73M CNY
• Revenue Growth: +266.85%
• P/S Ratio: 5.56
• Revenue / Employee: 3.57M CNY
• Employees: 207
• Market Cap: 4.75B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	53.53M	-102.18M	-65.62%
Dec 31, 2024	155.71M	92.19M	145.13%
Dec 31, 2023	63.52M	-32.23M	-33.66%
Dec 31, 2022	95.75M	-57.06M	-37.34%
Dec 31, 2021	152.81M	-333.48M	-68.58%

Data Source: S&P Global Market Intelligence Last updated: Sep 24, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 1, 2026

Data Sources Report a data error